Chronic muscle pain induced by repeated acid injection is reversed by spinally administered μ- and δ-, but not κ-, opioid receptor agonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 1146-1150

  Sluka, K A ^a   Rohlwing, J J ^a   Bussey, R A ^a   Eikenberry, S A ^a   Wilken, J M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ACID; DELTA OPIATE RECEPTOR AGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALTRINDOLE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOSE RESPONSE; GASTROCNEMIUS MUSCLE; HYPERALGESIA; MECHANICAL STIMULATION; MYALGIA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; HYPERALGESIA; INJECTIONS, SPINAL; MORPHINE; MUSCULAR DISEASES; PAIN THRESHOLD; PHYSICAL STIMULATION; PIPERAZINES; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0036721543     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.033167     Document Type: Article

References (46)

1. Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise
2. Tramadol in the fibromyalgia syndrome: A controlled clinical trial versus placebo
3. SNC 80, a selective, nonpeptidic and systemically active opioid δ agonist
4. Comparison of pre- versus post-incision administration of intrathecal bupivacaine and intrathecal morphine in a rat model of postoperative pain
5. Spinal μ and δ, but not κ, opioid receptor agonists attenuate responses to noxious colorectal distension in the rat
6. Effect of varying frequency, intensity and pulse duration of TENS on primary hyperalgesia in inflamed rats
7. 1-opioid receptors in the rat spinal cord: Studies with intrathecal 7-benzylidenenaltrexone
8. Differential effects of intrathecally administered δ- and μ-opioid receptor agonists on formalin evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat
9. Treatment of chronic allodynia in spinally injured rats: Effects of intrathecal selective opioid receptor agonists
10. 35S]GTP-γS binding in μ-receptor knockout mice
11. Effects of spinal κ-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons
12. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms
13. 1-13 and a kappa receptor agonist U50,388
14. A new animal model for assessing mechanisms and management of muscle hyperalgesia
15. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model
16. κ-opioid agonists produce antinociception after i. v. and i. c. v. but not intrathecal administration in the rat
17. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: Effects of naltrindole and its benzofuran analog (NTB)
18. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50, 488 and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction
19. Fibromyalgia and myofacial pain syndromes
20. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat
21. Antinociceptive and motor effects of δ/μ and κ/μ combinations of intrathecal opioid agonists
22. κ- and δ-opioid agonists synergize to produce potent analgesia
23. The role of δ-opioid receptor subtypes in neuropathic pain
24. Multiple opioid systems and pain
25. Systemic opioid analgesics
26. Characteristics of dose dependent antagonism by β-funaltrexamine of the antinociceptive effects of intrathecal μ agonists
27. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint
28. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve ligation injury
29. Inhibition by spinal morphine of the tail flick response is attenuated in rats with nerve ligation injury
30. Analgesia produced by intrathecal administration of the κ-opioid agonist, U50,488H, on formalin-evoked cutaneous pain in the rat
31. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats
32. Pharmacology of spinal opioids
33. Spinal κ-opioid receptor mediated antinociceptian is stimulus specific
34. Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline
35. Increased morphine reduces mechanical hyperalgesia induced by repeated intramuscular injections of pH 4.0 saline
36. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats
37. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia
38. Fibromyalgia-are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs
39. Alterations in neuronal excitability and the potency of spinal-μ, δ, and κ opioids after carrageenan-induced inflammation
40. Dynorphin A and related peptides administered intrathecally in the rat: A search for putative κ-opioid receptor activity
41. 4]deltorphin
42. 2-opioid receptors reduces carrageenan-induced hyperalgesia in the rat
43. Lumbar catheterization of the spinal subarachnoid space in the rat
44. Dose dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: Additional evidence for δ-opioid receptor subtypes in the rat
45. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve
46. The economic costs and social and psychological impact of musculoskeletal conditions